The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
PsychopharmacologyFull Access

Is Low T Contributing to Your Patient’s Depression?

Published Online:

Abstract

Multiple factors, including several psychiatric medications, may contribute to low testosterone in patients.

Photo: Justin Smith and Ryan Smith

Justin Smith, M.D., is an assistant professor of psychiatry at the University of Virginia. Ryan Smith, M.D., is an assistant professor of urology at the University of Virginia.

Although the symptoms of low testosterone frequently overlap with psychiatric symptoms, routine screening for low testosterone is rare in psychiatric settings (1).

Several studies point to an association between low testosterone levels and depression in men. A 2017 study comparing testosterone levels in men with and without depression found that men with major depressive disorder had lower average testosterone levels than non-depressed controls. This difference was not seen when the researchers compared hormone levels in women with and without depression (2). Although only a small percentage of men (5.4 percent) in the study had a total testosterone level lower than 230 ng/dL (considered below the normal range of testosterone for men), 90 percent of them met the criteria for major depressive disorder.

Another study tracked older men over a nine-year period. The researchers found that the risk of developing depression over the course of the study was nearly double in men with lower baseline testosterone levels even after adjusting for age, lifestyle factors, and medical comorbidities (3).

What options do you have if you suspect low testosterone (low T) may be contributing to mood symptoms in your patient?

To screen for testosterone deficiency, most clinicians rely on a 10-item questionnaire known as ADAM (Androgen Deficiency in Aging Males), which assesses energy, mood, and sexual performance. It is a good test in the general population, but in psychiatric settings, questions such as “Do you feel sad and/or grumpy?” or “Have you noticed a deterioration in your work performance?” may be less effective.

A better approach might be to ask your male patients with depression if they have had any problems with low libido, reduced frequency of morning erections, or other erectile dysfunction. If they answer yes to any of these questions, recommend a morning testosterone blood test. If the levels are below 300 ng/dL, you can consider the following treatment options:

  • Consider alternatives to current medications. Selective serotonin reuptake inhibitors (SSRIs) might contribute to testosterone loss, as laboratory studies have shown they can convert testosterone to estradiol (6). The antidepressants bupropion or mirtazapine might be better for patients experiencing low testosterone. The antidepressants bupropion or mirtazapine might be better for patients experiencing low testosterone. Studies also show that the long-term use of opioids is associated with testosterone loss, so taper patients off opioids, or use buprenorphine, if necessary (7). The antipsychotic risperidone is also known to suppress testosterone by raising prolactin levels in the body; in place of risperidone, you may want to prescribe aripiprazole.

  • Encourage weight loss if appropriate. Studies have suggested that just a 10 percent loss in body weight can boost testosterone by about 80 ng/dL (8). Such a jump in testosterone levels could be enough to take someone with significant deficiency back above 300 ng/dL.

  • Consider referring the patient to a urologist for testosterone replacement therapy. If your patient tests low for total testosterone levels, you may want to refer him to a urologist for testosterone replacement therapy (TRT). In 2015, the Food and Drug Administration issued a black box warning about TRT, stating it should only be used in people with testosterone deficiency due to pituitary, testicular, or brain problems. Because the studies used in the FDA’s decision had some statistical problems and used poor comparison groups, several medical groups including the American Urological Association have said they believe TRT remains appropriate for men with demonstrated low T and significant hypogonadism-related symptoms, absent contraindications such as male breast cancer. Testosterone replacement has a contraceptive effect, so ensure patients have no concerns about preserving fertility.

1. Smith JB, Rosen J, Colbert A. Low Serum Testosterone in Outpatient Psychiatry Clinics: Addressing Challenges to the Screening and Treatment of Hypogonadism. Sex Med Rev. 2018 Jan; 6(1):69-76.

2. Giltay EJ, van der Mast RC, Lauwen E, et al. Plasma Testosterone and the Course of Major Depressive Disorder in Older Men and Women. Am J Geriatr Psychiatry. 2017; 25(4):425-437.

3. Ford AH, Yeap BB, Flicker L, et al. Prospective Longitudinal Study of Testosterone and Incident Depression in Older Men: The Health in Men Study. Psychoneuroendocrinology. 2016; 64:57-65.

4. Amanatkar HR, Chibnall JT, Seo BW, et al. Impact of Exogenous Testosterone on Mood: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. Ann Clin Psychiatry. 2014; 26(1):19-32.

5. Travison TG, Vesper HW, Orwoll E, et al. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe. J Clin Endocrinol Metab. 2017; 102(4):1161-1173.

6. Hansen CH, Larsen LW, Sørensen AM, et al. The Six Most Widely Used Selective Serotonin Reuptake Inhibitors Decrease Androgens and Increase Estrogens in the H295R Cell Line. Toxicol In Vitro. 2017; 41:1-11.

7. Rubinstein AL, Carpenter DM, Minkoff JR. Hypogonadism in Men With Chronic Pain Linked to the Use of Long-acting Rather Than Short-acting Opioids. Clin J Pain. 2013; 29:840-845.

8. Corona G, Rastrelli G, Monami M, et al. Body Weight Loss Reverts Obesity-associated Hypogonadotropic Hypogonadism: A Systematic Review and Meta-analysis. Eur J Endocrinol. 2013; 168:829-843.